Description: This article describes the LEARN program which provides state regulators with a convenient means of obtaining the knowledge base needed to understand how reinsurance works. It is an update of the article originally published in the July 2011 issue Reinsurance News.

Description: Panelists discuss the current climate for Critical Illness insurance in the United States. Topics include product design, pricing, underwriting, and marketing high-end products. From Record of Society of Actuaries, Vol. 30, No. 3, Session 11

Description: The article provides an update on the activities of the LEARN Program in 2014 and 2015.

Description: Panelists discuss current implications of the MMA on Medicare Advantage, Medicare Supplement plans, and introduce the new Part D prescription drug benefit. From the Record of the Society of Actuaries, Vol. 31, No. 2, Session 107

Description: This session provides an overview of industry approaches to valuing the liabilities of nontraditional health products. Liabilities for losses that have been incurred but not reported and for losses that have been reported but not paid are examined. Includes a discussion on employer specific stop-loss, provider excess loss, critical illness and cancer insurance. From the Record of the Society of Actuaries, Volume 28, No. 2, Session 133

Description: The panel offers a summary of the Medicare Modernization Act signed into law in 2003, which implemented sweeping changes to the Medicare program. Topics include Medicare Advantage, the impact on Medicare Supplement, Part D, and the impact on retiree health plans. From Record of Society of Actuaries, Vol. 30, No. 3, Session 127

Description: This session discusses Medicare Supplement Insurance including claim cost experience and trend, Medicare Select issues and challenges, and meeting rate increase/profitability objectives. From the Record of the Society of Actuaries, Volume 29, No. 2, Session 7

Description: An overview of the Medicare Supplement landscape and the critical factors for successfully pricing and managing this product line amidst the challenges that exist.